4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083609
Options or other derivatives
- Chief Executive Officer acquired 54,623 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TABUTEAU HERRIOT Chief Executive Officer | 2026-02-26 | Grant or award · Restricted Stock Units | +54,623 | 54,623 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…